HeartSciences (HSCSW) Other Accumulated Expenses (2022 - 2026)

HeartSciences has reported Other Accumulated Expenses for 5 years, with the latest figure at $84898.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 17.09% year-over-year to $84898.0; the trailing twelve-month figure through Jan 2026 stood at $84898.0 (down 17.09% YoY), and the FY2025 full-year result was $29927.0, down 12.36% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $84898.0, down from $148572.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $389186.0 in Q3 2022, with the low at $1220.0 in Q2 2022.
• Historically, Other Accumulated Expenses has averaged $151498.1 across 5 years, with a median of $153596.0 in 2023.
• The largest YoY upside for Other Accumulated Expenses was 3883.28% in 2023 against a maximum downside of 45.62% in 2023.
• HeartSciences' Other Accumulated Expenses stood at $291670.0 in 2022, then plunged by 45.62% to $158620.0 in 2023, then rose by 9.47% to $173644.0 in 2024, then fell by 14.44% to $148572.0 in 2025, then plunged by 42.86% to $84898.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $84898.0 (Q1 2026), $148572.0 (Q4 2025), and $215334.0 (Q3 2025), per Business Quant data.